Trade Mark Journal No.2026/036 4 September 2026
UK00004435010 24 August 2026 (5,42)
IMMUTRIN
- Class 5
- Pharmaceutical preparations; biopharmaceutical preparations; pharmaceutical preparations for use in the treatment of systemic amyloidosis; pharmaceutical preparations for use in the treatment of cardiovascular disease; antibody preparations for medical purposes; pharmaceutical preparations for the treatment and prevention of rare and genetic diseases; antibodies.
- Class 42
- Scientific and medical research and development in the field of pharmaceuticals; scientific and medical research and development in the field of biotechnology; scientific and medical research and development in the field of immunotherapy; scientific and medical research and development in the field of antibody technology; scientific and medical research in the field of rare and genetic diseases; research and development of pharmaceutical products; drug discovery and development services; biotechnology testing; testing of pharmaceuticals; conducting clinical trials; information, advice and consultancy services in relation to all the aforesaid services.
Immutrin Ltd
Representative: Kilburn & Strode LLP